Who owns CanFite Biopharma Ltd ADR?
- Ticker: CANF
- CUSIP Number: 13471n409
Tip: Access positions for across all investors
Analyze quarterly positions in CanFite Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of CanFite Biopharma stock
Who bought or sold CanFite Biopharma Ltd ADR this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Citadel Advisors | 34k | $106k | 100% | Mar 2026 |
|
| Rhumbline Advisers | 21k | $65k | 100% | Mar 2026 |
|
| Hrt Financial | 19k | $60k | 100% | Mar 2026 |
|
| Citigroup | 5.5k | $17k | 100% | Mar 2026 |
|
| UBS Group | 2.2k | $6.7k | 100% | Mar 2026 |
|
| Fifth Third Bancorp | 150.00 | $465.000000 | 100% | Mar 2026 |
|
| Wells Fargo & Company | 125.00 | $388.000000 | 100% | Mar 2026 |
|
| Activest Wealth Management | 10.00 | $31.000000 | 100% | Mar 2026 |
|
| Efficient Wealth Management | 5.00 | $0 | 100% | Mar 2026 |
|
| Morgan Stanley | 1.00 | $3.000000 | 100% | Mar 2026 |
|
| TD Waterhouse Canada | 1.00 | $3.000000 | 100% | Mar 2026 |
|
Who sold out of CanFite Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| SBI Securities | Dec 2025 | 1.00 | $0 |